Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/2003
08/21/2003US20030157071 Hormone replacement therapy; transduction bone marrow cells; cell differentiation
08/21/2003US20030157070 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
08/21/2003US20030157069 Administering polypeptide; them radiation and drug therapy
08/21/2003US20030157066 Compositions comprising viruses and methods for concentrating virus preparations
08/21/2003US20030157065 Gene therapy; gene encoding drug metabolizing enzyme
08/21/2003US20030157064 Actin gene promoter; genetic engineered polypeptide; cardiovascular disorders
08/21/2003US20030157063 Infection therapy; viricides; gene therapy; immunoglobulins
08/21/2003US20030157059 Vaccine; infection therapy
08/21/2003US20030157055 Modified cytokines for use in cancer therapy
08/21/2003US20030157030 Methods and compositions for therapeutic use of rna interference
08/21/2003CA2513198A1 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003CA2491547A1 Methods and composition for modulating type i muscle formation using pgc-1.alpha.-
08/21/2003CA2476530A1 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
08/21/2003CA2476366A1 Cancer therapy
08/21/2003CA2475928A1 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds
08/21/2003CA2475838A1 Cytotoxic t-cell epitopes from chlamydia
08/21/2003CA2475802A1 Methods and compositions for use in spliceosome mediated rna trans-splicing
08/21/2003CA2475522A1 Method of radio-labelling biomolecules
08/21/2003CA2475102A1 Stabilized synthetic immunogen delivery systems
08/21/2003CA2474844A1 Cks1 inhibitors
08/21/2003CA2471392A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/20/2003EP1336619A2 Combination of a HVEM-LIGHT inhibitor and an immunosuppressive agent in the treatment or prevention of immune disorders
08/20/2003EP1335987A2 Modified vaccinia ankara virus variant
08/20/2003EP1335981A2 13237, 18480, 2245 or 16228 human protein kinase molecules and uses therefor
08/20/2003EP1335976A2 Modifier of organelle metalbolism
08/20/2003EP1335938A2 Apolipoprotein analogues
08/20/2003EP1335933A2 Pna analogues
08/20/2003EP1335926A2 Method of separating extra-chromosomal dna from other cellular components
08/20/2003EP1335749A2 Use of a helminth for the in vivo delivery of a medicament
08/20/2003EP1335746A2 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
08/20/2003EP1335745A1 Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer
08/20/2003EP1335741A2 METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP0868511B1 Utrophin gene expression
08/20/2003EP0721510B1 Anti-cancer gene therapy by modulation of immune or inflammatory response
08/20/2003CN1437654A Antigenic proteins of shrimp white spot syndrome virus uses thereof
08/20/2003CN1437652A Compounds and methods for treatment and diagnosis of chlamydial infection
08/20/2003CN1437477A A Memory enhancing protein
08/20/2003CN1436789A livestock castration vaccine gene and recombinant gene vector
08/20/2003CN1118569C (-)-strand RNA virus vector having autonomously replicating activity
08/19/2003US6608238 Incorporation of a DNA sequence into the secretory cells of the mammary gland to alter the milk composition; solution comprising the retroviral particles is displaced upwards using a substance with a higher density
08/19/2003US6608191 Antisense oligonucleotide of given sequence; capable of inhibiting the function of viral RNA
08/19/2003US6608182 Human vascular endothelial growth factor 2
08/19/2003US6608038 Methods and compositions for treatment of diabetes and related conditions via gene therapy
08/19/2003US6608037 TCF responsive element
08/19/2003US6608036 Oligonucleotide N3′→P5′ thiophosphoramidates: their synthesis and administration to treat neoplasms
08/19/2003US6608034 Immunovectors for the intracellular and intranuclear transport
08/19/2003US6607912 Genetically engineered baculovirus for use as a tool in gene therapy
08/19/2003US6607884 Oligonucleotide probes; hybridization; polynucleotides; use for modulating muscle cell and adipose tissue growth and detection of cell proliferative disorder of muscle, nerve or fat tissues
08/19/2003US6607882 Regulation of endogenous gene expression in cells using zinc finger proteins
08/19/2003US6607880 Methods and reagents for modulating apoptosis
08/19/2003US6607724 Administering fragments, conformations, biological equivalent, or derivatives of antithrombin III; anticancer agents
08/19/2003US6607720 Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction
08/19/2003CA2122613C Targeted delivery of virus vector to mammalian cells
08/14/2003WO2003066892A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066868A1 Retroviral vectors pseudotyped with influenza virus hemagglutinin for gene delivery
08/14/2003WO2003066860A1 Angiogenesis inhibitors
08/14/2003WO2003066858A1 Trans-splicing ribozymes transferring elements derived from sequences encoding fluorescent proteins
08/14/2003WO2003066854A1 Anticancer agents using vero toxin variants
08/14/2003WO2003066840A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
08/14/2003WO2003066825A2 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066813A2 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE
08/14/2003WO2003066810A2 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003WO2003066808A2 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
08/14/2003WO2003066674A2 Viral cd30 polypeptide
08/14/2003WO2003066650A2 Short interfering rna molecules directed towards a tissue factor coding nucleic acid
08/14/2003WO2003066104A2 Pharmaceutical composition which improves in vivo gene transfer
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066087A2 Kinases involved in the regulation of energy homeostasis
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066082A1 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage
08/14/2003WO2003066080A1 Compositions and methods for promoting lipid mobilization, glycogen mobilization, or both, in humans
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066054A1 Cationic polymers for use in therapeutic agent delivery
08/14/2003WO2003065994A2 Schwann cell and phosphodiesterase inhibitors based therapy
08/14/2003WO2003065985A2 Uses of mammalian cytokine; related reagents
08/14/2003WO2003065984A2 Methods and compositions for treating cardiovascular disease
08/14/2003WO2003065871A2 Methods and compositions for treating hematological disorders
08/14/2003WO2003045325A3 Dopaminergic stimulatory factor
08/14/2003WO2003035845A3 Salvador tumor suppressor gene
08/14/2003WO2003030935A3 Adjuvants for nucleic acid vaccines
08/14/2003WO2003029433A3 Chimeric viral vectors for gene therapy
08/14/2003WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
08/14/2003WO2003018768A3 Transmembrane protein differentially expressed in cancer
08/14/2003WO2003012051A8 Inhibitor of dna methylation
08/14/2003WO2003010184A3 A conserved xiap-interaction motif in caspase-9 and smac/diablo for mediating apoptosis
08/14/2003WO2003009813A3 Methods of treating neuropilin-mediated diseases
08/14/2003WO2003002069A3 Intradermal delivery of vaccines and gene therapeutic agents via microcannula
08/14/2003WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof
08/14/2003WO2002083902A3 Adenovirus serotype 30 (ad30) fiber protein and uses thereof
08/14/2003WO2002058626A3 Methods and compositions for the identification and treatment of neurodegenerative disorders
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002051438A3 Use of repulsive guidance molecule (rgm) and its modulators
08/14/2003WO2002039116A3 Retrovirus isolated from humans
08/14/2003WO2002038601A3 Foggy
08/14/2003WO2002028420A3 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
08/14/2003WO2002024735A3 Peptide inhibitors of hiv entry
08/14/2003WO2002018609A9 Methods for stable transduction of cells with viral vectors
1 ... 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 ... 870